We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$24.6B
AUM Growth
+$2.47B
(+11%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
25.43%
Holding
1,038
New
49
Increased
357
Reduced
452
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$131M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$116M |
| 3 |
Visa
V
|
+$111M |
| 4 |
Home Depot
HD
|
+$85.9M |
| 5 |
S&P Global
SPGI
|
+$82.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$43M |
| 2 |
West Pharmaceutical
WST
|
+$42.6M |
| 3 |
Church & Dwight Co
CHD
|
+$40.9M |
| 4 |
Fair Isaac
FICO
|
+$39.7M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.11% |
| 2 | Financials | 13.59% |
| 3 | Healthcare | 12.97% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Match Group
MTCH
$8.55B
| $448K | ﹤0.01% |
10,699
-236,975
| -96% | -$8.66M |
|
827
Louisiana-Pacific
LPX
$5.49B
| $446K | ﹤0.01% |
5,943
-2,059
| -26% | -$127K |
|
828
Loews
L
$23.6B
| $445K | ﹤0.01% |
7,497
-83,095
| -92% | -$4.81M |
|
829
Clean Harbors
CLH
$16.3B
| $438K | ﹤0.01% |
+2,665
| New | +$390K |
|
830
Murphy USA
MUSA
$9.61B
| $437K | ﹤0.01% |
+1,406
| New | +$394K |
|
831
Royalty Pharma
RPRX
$25.3B
| $432K | ﹤0.01% |
14,047
-4,983
| -26% | -$169K |
|
832
Advanced Drainage Systems
WMS
$10.9B
| $430K | ﹤0.01% |
+3,776
| New | +$356K |
|
833
Encompass Health
EHC
$12.4B
| $428K | ﹤0.01% |
+6,320
| New | +$396K |
|
834
Casey's General Stores
CASY
$30.9B
| $425K | ﹤0.01% |
+1,743
| New | +$395K |
|
835
WEC Energy
WEC
$35.1B
| $418K | ﹤0.01% |
4,736
| – | – |
|
836
Charles River Laboratories
CRL
$12.8B
| $409K | ﹤0.01% |
1,945
-59,026
| -97% | -$11.7M |
|
837
NewMarket
NEU
$8.18B
| $401K | ﹤0.01% |
+996
| New | +$388K |
|
838
Okta
OKTA
$25.8B
| $396K | ﹤0.01% |
5,712
-71,140
| -93% | -$5.4M |
|
839
Regency Centers
REG
$14.1B
| $395K | ﹤0.01% |
6,387
-184
| -3% | -$10.9K |
|
840
Burlington
BURL
$23.2B
| $394K | ﹤0.01% |
2,502
-36,418
| -94% | -$6.25M |
|
841
Reinsurance Group of America
RGA
$16.1B
| $391K | ﹤0.01% |
+2,817
| New | +$401K |
|
842
Globe Life
GL
$14.3B
| $381K | ﹤0.01% |
3,479
-4,348
| -56% | -$467K |
|
843
Universal Health Services
UHS
$10.5B
| $376K | ﹤0.01% |
2,386
-2,160
| -48% | -$301K |
|
844
Equitable Holdings
EQH
$14.1B
| $372K | ﹤0.01% |
13,701
-502,234
| -97% | -$12.7M |
|
845
Fidelity National Financial
FNF
$13.5B
| $367K | ﹤0.01% |
10,204
-25,692
| -72% | -$896K |
|
846
Brookfield Asset Management
BAM
$83.8B
| $366K | ﹤0.01% |
11,206
-110,450
| -91% | -$3.55M |
|
847
Liberty Broadband Class C
LBRDK
$5.15B
| $362K | ﹤0.01% |
4,524
-101
| -2% | -$7.81K |
|
848
Imperial Oil
IMO
$60.4B
| $362K | ﹤0.01% |
7,068
-60
| -0.8% | -$2.98K |
|
849
Douglas Emmett
DEI
$1.96B
| $362K | ﹤0.01% |
28,769
| – | – |
|
|
DAY
850
DELISTED
Dayforce
DAY
| $358K | ﹤0.01% |
5,346
+125
| +2% | +$8.04K |
|
Similar funds
QCM
NAMI
Aviva's Q2 2023 Portfolio in Review
As of Q2 2023, Aviva held 1,038 positions worth $24.6B, up 11% from $22.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Aviva's Q2 2023 filing shows 49 new, 357 increased, 452 reduced and 75 closed positions. Its largest new stake was ATS Corp: 438,979 shares worth $20.2M. The largest sale was Marathon Petroleum, an estimated $43M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2023 buy was ATS Corp: 438,979 shares worth $20.2M.
- Aviva added most to ExxonMobil in Q2 2023, an estimated $131M increase.
- Aviva's biggest Q2 2023 reduction was Marathon Petroleum, cutting an estimated $43M.
- Aviva fully exited United Therapeutics in Q2 2023, selling an estimated $20.4M.
- Aviva's ten largest holdings make up 25% of its $24.6B portfolio in Q2 2023.
- Aviva opened 49 new positions and closed 75 in Q2 2023.
- Aviva's portfolio value rose 11% quarter-over-quarter to $24.6B.
Based on Aviva's 13F filing for Q2 2023, filed 10 Aug 2023.